Endoscopic surveillance of Lynch syndrome at a highly specialized center in Sweden: An observational study of interval colorectal cancer and individual risk factors

被引:4
作者
Jamizadeh, Nigin [1 ]
Bernstedt, Sophie Walton [1 ,2 ,3 ]
Haxhijaj, Adrianna [1 ]
Andreasson, Anna [1 ]
Bjork, Jan [2 ,4 ]
Forsberg, Anna [5 ]
Backman, Ann-Sofie [1 ,6 ]
机构
[1] Karolinska Inst, Dept Med Huddinge, Unit Gastroenterol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Div Gastroenterol, Med Unit Gastroenterol Dermatovenereol & Rheumatol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Div Upper Gastrointestinal Dis, Stockholm, Sweden
[4] Karolinska Univ Hosp, Hereditary Canc Unit, Theme Canc, Stockholm, Sweden
[5] Karolinska Inst, Dept Med Solna, Div Clin Epidemiol, Stockholm, Sweden
[6] Ersta Hosp, Dept Med, Div Gastroenterol, Stockholm, Sweden
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
Lynch syndrome (LS); colorectal cancer; interval cancer; surveillance; colonoscopy; ASPIRIN; PREVENTION; PHENOTYPE; ADENOMAS; FAMILIES; REGISTRY; PMS2;
D O I
10.3389/fonc.2023.1127707
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionLynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC). In order to detect CRCs amongst LS patients, regular colonoscopies are recommended. However, an international agreement on an optimal surveillance interval has not yet been reached. In addition, few studies have investigated factors that could potentially increase the CRC risk amongst LS patients. AimsThe primary aim was to describe the frequency of CRCs detected during endoscopic surveillance and to estimate the interval from a clean colonoscopy to CRC detection amongst LS patients. The secondary aim was to investigate individual risk factors, including sex, LS genotype, smoking, aspirin use and body mass index (BMI), on CRC risk amongst patients that develop CRC before and during surveillance. Material and methodsClinical data and colonoscopy findings from 366 LS patients' 1437 surveillance colonoscopies were collected from medical records and patient protocols. Logistic regression and Fisher's exact test were used to investigate associations between individual risk factors and CRC development. Mann-Whitney U test was used to compare the distribution of TNM stages of CRC detected before surveillance and after index. ResultsCRC was detected in 80 patients before surveillance and in 28 patients during surveillance (10 at index and 18 after index). During the surveillance programme, CRC was detected within 24 months in 65% of the patients, and after 24 months within 35% of the patients. CRC was more common amongst men, previous and current smokers, and the odds of developing CRC also increased with an increasing BMI. CRCs were more often detected amongst MLH1 and MSH2 carriers during surveillance, compared to the other genotypes. ConclusionsWe found that 35% of the CRC cases detected during surveillance were found after 24 months. MLH1 and MSH2 carriers were at higher risk of developing CRC during surveillance. Additionally, men, current or previous smokers, and patients with a higher BMI were at higher risk of developing CRC. Currently, LS patients are recommended a "one-size-fits-all" surveillance program. The results support the development of a risk-score whereby individual risk factors should be taken into consideration when deciding on an optimal surveillance interval.
引用
收藏
页数:9
相关论文
共 28 条
  • [1] [Anonymous], 2022, COL CANC AW MONTH
  • [2] Room for improvement: One third of Lynch syndrome patients presenting for genetic testing in a highly specialised centre in Stockholm already have cancer
    Bernstedt, Sophie Walton
    Bjork, Jan
    Fritzell, Kaisa
    Spigelman, Allan D.
    Bjorck, Erik
    Backman, Ann-Sofie
    [J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2021, 19 (01)
  • [3] Recent advances in Lynch syndrome
    Biller, Leah H.
    Syngal, Sapna
    Yurgelun, Matthew B.
    [J]. FAMILIAL CANCER, 2019, 18 (02) : 211 - 219
  • [4] Body Mass Index Increases Risk of Colorectal Adenomas in Men With Lynch Syndrome: The GEOLynch Cohort Study
    Botma, Akke
    Nagengast, Fokko M.
    Braem, Marieke G. M.
    Hendriks, Jan C. M.
    Kleibeuker, Jan H.
    Vasen, Hans F. A.
    Kampman, Ellen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : 4346 - 4353
  • [5] Burn J, 2020, LANCET, V395, P1855, DOI 10.1016/S0140-6736(20)30366-4
  • [6] Decrease in mortality in Lynch syndrome families because of surveillance
    De Jong, AE
    Hendriks, YMC
    Kleibeuker, JH
    De Boer, SY
    Cats, A
    Griffioen, G
    Nagengast, FM
    Nelis, FG
    Rookus, MA
    Vasen, HFA
    [J]. GASTROENTEROLOGY, 2006, 130 (03) : 665 - 671
  • [7] No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies
    Engel, Christoph
    Vasen, Hans F.
    Seppala, Toni
    Aretz, Stefan
    Bigirwamungu-Bargeman, Marloes
    de Boer, Sybrand Y.
    Bucksch, Karolin
    Buttner, Reinhard
    Holinski-Feder, Elke
    Holzapfel, Stefanie
    Hueneburg, Robert
    Jacobs, Maarten A. J. M.
    Jarvinen, Heikki
    Kloor, Matthias
    Doeberitz, Magnus von Knebel
    Koornstra, Jan J.
    van Kouwen, Mariette
    Langers, Alexandra M.
    van de Meeberg, Paul C.
    Morak, Monika
    Moeslein, Gabriela
    Nagengast, Fokko M.
    Pylvanainen, Kirsi
    Rahner, Nils
    Renkonen-Sinisalo, Laura
    Sanduleanu, Silvia
    Schackert, Hans K.
    Schmiegel, Wolff
    Schulmann, Karsten
    Steinke-Lange, Verena
    Strassburg, Christian P.
    Vecht, Juda
    Verhulst, Marie-Louise
    Cappel, Wouter de Vos Tot Nederveen
    Zachariae, Silke
    Mecklin, Jukka-Pekka
    Loeffler, Markus
    [J]. GASTROENTEROLOGY, 2018, 155 (05) : 1400 - +
  • [8] Efficacy of Annual Colonoscopic Surveillance in Individuals With Hereditary Nonpolyposis Colorectal Cancer
    Engel, Christoph
    Rahner, Nils
    Schulmann, Karsten
    Holinski-Feder, Elke
    Goecke, Timm O.
    Schackert, Hans K.
    Kloor, Matthias
    Steinke, Verena
    Vogelsang, Holger
    Moeslein, Gabriela
    Goergens, Heike
    Dechant, Stefan
    Doeberitz, Magnus Von Knebel
    Rueschoff, Josef
    Friedrichs, Nicolaus
    Buettner, Reinhard
    Loeffler, Markus
    Propping, Peter
    Schmiegel, Wolff
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (02) : 174 - 182
  • [9] Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with lynch syndrome:: A report by the German HNPCC Consortium
    Goecke, Timm
    Schulmann, Karsten
    Engel, Christoph
    Holinski-Feder, Elke
    Pagenstecher, Constanze
    Schackert, Hans K.
    Kloor, Matthias
    Kunstmann, Erdmute
    Vogelsang, Holger
    Keller, Gisela
    Dietmaier, Wolfgang
    Mangold, Elisabeth
    Friedrichs, Nicolaus
    Propping, Peter
    Krueger, Stefan
    Gebert, Johannes
    Schmiegel, Wolff
    Rueschoff, Josef
    Loeffler, Markus
    Moeslein, Gabriela
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) : 4285 - 4292
  • [10] Yield of Lynch Syndrome Surveillance for Patients With Pathogenic Variants in DNA Mismatch Repair Genes
    Goverde, Anne
    Eikenboom, Ellis L.
    Viskil, Ellemieke L.
    Bruno, Marco J.
    Doukas, Michael
    Dinjens, Winand N. M.
    Dubbink, Erik Jan
    van den Ouweland, Ans M. W.
    Hofstra, Robert M. W.
    Wagner, Anja
    Spaander, Manon C. W.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1112 - +